Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;51(5):e13537.
doi: 10.1111/eci.13537. Epub 2021 Mar 17.

COVID-19 re-infection

Philippe Brouqui  1   2 , Philippe Colson  1   2 , Cléa Melenotte  1   2 , Linda Houhamdi  1   2 , Marielle Bedotto  2 , Christian Devaux  1   2 , Philipe Gautret  1   3 , Matthieu Million  1   2 , Philippe Parola  1   3 , Didier Stoupan  2 , Bernard La Scola  1   2 , Jean-Christophe Lagier  1   2 , Didier Raoult  1   2
Affiliations

COVID-19 re-infection

Philippe Brouqui et al. Eur J Clin Invest. 2021 May.
No abstract available

Keywords: COVID-19; ICU; SARS Cov2; death; immunity; mutant; prognosis; re-infection; vaccine; variant.

PubMed Disclaimer

Conflict of interest statement

All authors are not in conflict of interest with the content of this manuscript.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Coronavirus Update (Live): 96,750,697 Cases and 2,068,974 Deaths from COVID‐19 Virus Pandemic ‐ Worldometer [Internet]. https://www.worldometers.info/coronavirus/#countries [Accessed 12 April 2021].
    1. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903‐1915. - PubMed
    1. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol. 1983;37(1):529‐549. - PubMed
    1. Tsang TK, Ghebremariam SL, Gresh L, et al. Effects of infection history on dengue virus infection and pathogenicity. Nat Commun. 2019;10(1):1246. - PMC - PubMed
    1. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS‐CoV‐2 ‐ preliminary report. N Engl J Med. 2020;383(20):1920‐1931. - PMC - PubMed

MeSH terms